Profile
Douglas Maffei is currently the Vice President-Investor Relations at Seagen Inc. He previously worked as a Senior Director-Investor Relations at Gilead Sciences, Inc.
Douglas Maffei active positions
| Companies | Position | Start |
|---|---|---|
| SEAGEN INC. | Investor Relations Contact | - |
Former positions of Douglas Maffei
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Douglas Maffei
